Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. (Q36212412)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. |
scientific article |
Statements
Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10 (English)
Laurence E McCahill
Saima Sharif
Nicholas J Petrelli
Lily Lau Lai
Naftali Bechar
Jeffrey K Giguere
Shaker R Dakhil
Louis Fehrenbacher
Samia H Lopa
Lawrence D Wagman
Michael J O'Connell
Norman Wolmark
1 reference
1 reference
1 reference
1 reference
1 reference